PCSK9 and atherosclerosis: In 2003, a novel gain-of-function (GOF) mutation within the PCSK9 gene, contributing to a phenotype with markedly elevated LDL-C levels and premature ASCVD, has been identified in patients with severe hypercholesterolemia [7].